We are live on ! Find out more
PP

Palladium Partners Portfolio holdings

AUM $2.28B
1-Year Est. Return 12.96%
This Fund
S&P 500
This Quarter Est. Return
+1.78%
1 Year Est. Return
+12.96%
3 Year Est. Return
+64.31%
5 Year Est. Return
+102.3%
10 Year Est. Return
–
AUM
$1.17B
AUM Growth
+$13.7M
Cap. Flow
+$3.13M
Cap. Flow %
0.27%
Top 10 Hldgs %
23.42%
Holding
261
New
6
Increased
53
Reduced
155
Closed
9

Top Buys

Rank Stock Value
1
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$4.26M
2
GILD icon
Gilead Sciences
GILD
+$4.2M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$2.63M
4
DGS icon
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
+$2.04M
5
AGN
Allergan plc
AGN
+$1.93M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$3.27M
2
CMCSA icon
Comcast
CMCSA
+$2.58M
3
BP icon
BP
BP
+$1.61M
4
PG icon
Procter & Gamble
PG
+$1.37M
5
IBM icon
IBM
IBM
+$1.16M

Sector Composition

Rank Sector Weight
1 Technology 13.12%
2 Financials 11.75%
3 Healthcare 11.15%
4 Industrials 10.1%
5 Consumer Staples 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APYX icon
251
Apyx Medical
APYX
$173M
$24K ﹤0.01%
10,000
– –
CTHR
252
DELISTED
Charles & Colvard Ltd
CTHR
$19K ﹤0.01%
1,585
-3,121
-66% -$46.7K
BAX icon
253
Baxter International
BAX
$13.8B
– –
-5,407
Closed -$215K
BRO icon
254
Brown & Brown
BRO
$23.7B
– –
-15,538
Closed -$256K
LHX icon
255
L3Harris
LHX
$50.7B
– –
-2,925
Closed -$210K
NVS icon
256
Novartis
NVS
$301B
– –
-2,455
Closed -$204K
TEVA icon
257
Teva Pharmaceuticals
TEVA
$41.2B
– –
-7,500
Closed -$431K
UPS icon
258
United Parcel Service
UPS
$89.5B
– –
-1,815
Closed -$202K
CCEC
259
Capital Clean Energy Carriers
CCEC
$1.35B
– –
-2,857
Closed -$160K
MMP
260
DELISTED
Magellan Midstream Partners, L.P.
MMP
– –
-2,565
Closed -$212K
CB
261
DELISTED
CHUBB CORPORATION
CB
– –
-2,019
Closed -$209K
7 8 9 10
11

Similar funds

ACM
Azimuth Capital Management Bloomfield Hills, Michigan $2.34B AUM 16.67% 1-Year Est. Return
ACI
AMP Capital Investors Sydney, Australia $2.37B AUM 23.59% 1-Year Est. Return
BAM
Barrett Asset Management New York $2.39B AUM 14.06% 1-Year Est. Return
SCC
Spring Creek Capital Wichita, Kansas $2.53B AUM 19.59% 1-Year Est. Return
IA
IndexIQ Advisors New York $2.82B AUM 12.48% 1-Year Est. Return
MXM
Mayfield XIV Management Menlo Park, California $1.35B AUM
OSIA
O'Shares Investment Advisers Boston, Massachusetts $1.27B AUM 6.63% 1-Year Est. Return
MAM
Majedie Asset Management London, United Kingdom $1.22B AUM 16.08% 1-Year Est. Return

Palladium Partners's Q1 2015 Portfolio in Review

As of Q1 2015, Palladium Partners held 261 positions worth $1.17B, up 1.2% from $1.15B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Palladium Partners's Q1 2015 filing shows 6 new, 53 increased, 155 reduced and 9 closed positions. Its largest new stake was Vanguard Morningstar Large-Cap ETF: 6,567 shares worth $625K. The largest sale was Amgen, an estimated $3.27M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Financials and Healthcare.

  • Palladium Partners's largest Q1 2015 buy was Vanguard Morningstar Large-Cap ETF: 6,567 shares worth $625K.
  • Palladium Partners added most to Vanguard FTSE Developed Markets ETF in Q1 2015, an estimated $4.26M increase.
  • Palladium Partners's biggest Q1 2015 reduction was Amgen, cutting an estimated $3.27M.
  • Palladium Partners fully exited Teva Pharmaceuticals in Q1 2015, selling an estimated $431K.
  • Palladium Partners's ten largest holdings make up 23% of its $1.17B portfolio in Q1 2015.
  • Palladium Partners opened 6 new positions and closed 9 in Q1 2015.
  • Palladium Partners's portfolio value rose 1.2% quarter-over-quarter to $1.17B.

Based on Palladium Partners's 13F filing for Q1 2015, filed 11 May 2015.